MA51339A - Procédé de préparation de composés pyrimidinyl-4-aminopyrazole - Google Patents
Procédé de préparation de composés pyrimidinyl-4-aminopyrazoleInfo
- Publication number
- MA51339A MA51339A MA051339A MA51339A MA51339A MA 51339 A MA51339 A MA 51339A MA 051339 A MA051339 A MA 051339A MA 51339 A MA51339 A MA 51339A MA 51339 A MA51339 A MA 51339A
- Authority
- MA
- Morocco
- Prior art keywords
- pyrimidinyl
- preparation
- aminopyrazole compounds
- aminopyrazole
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Psychology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762608398P | 2017-12-20 | 2017-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA51339A true MA51339A (fr) | 2020-10-28 |
Family
ID=66994244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA051339A MA51339A (fr) | 2017-12-20 | 2018-12-19 | Procédé de préparation de composés pyrimidinyl-4-aminopyrazole |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11834438B2 (fr) |
| EP (1) | EP3727377B1 (fr) |
| JP (1) | JP7284172B2 (fr) |
| KR (1) | KR20200100757A (fr) |
| CN (1) | CN112088003B (fr) |
| AU (1) | AU2018392599A1 (fr) |
| BR (1) | BR112020012611A2 (fr) |
| CA (1) | CA3086182A1 (fr) |
| ES (1) | ES2975958T3 (fr) |
| IL (1) | IL275480B2 (fr) |
| MA (1) | MA51339A (fr) |
| MX (1) | MX2020006641A (fr) |
| SG (1) | SG11202005752PA (fr) |
| WO (1) | WO2019126383A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112088003B (zh) | 2017-12-20 | 2023-10-13 | 戴纳立制药公司 | 制备嘧啶基-4-氨基吡唑化合物的工艺 |
| AR118641A1 (es) * | 2019-04-11 | 2021-10-20 | Denali Therapeutics Inc | Compuestos, composiciones y métodos |
| CN115894456A (zh) * | 2022-11-13 | 2023-04-04 | 药康众拓(江苏)医药科技有限公司 | 一种氘代吡唑氨基嘧啶类化合物、药物组合物和用途 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20130216A1 (es) | 2010-05-21 | 2013-02-27 | Incyte Corp | Formulacion topica para un inhibidor de jak |
| ES2577829T3 (es) | 2010-06-04 | 2016-07-19 | F. Hoffmann-La Roche Ag | Derivados de aminopirimidina como moduladores de la LRRK2 |
| GB201015949D0 (en) | 2010-09-22 | 2010-11-03 | Medical Res Council Technology | Compounds |
| NO2638031T3 (fr) * | 2010-11-10 | 2018-03-10 | ||
| AR089182A1 (es) | 2011-11-29 | 2014-08-06 | Hoffmann La Roche | Derivados de aminopirimidina como moduladores de lrrk2 |
| MX348920B (es) | 2011-11-29 | 2017-07-04 | Genentech Inc | Derivados de 2-(fenil o pirid-3-il)aminopirimidina como moduladores de proteina cinasa 2 de repeticion rica en leucina (lrrk2) para el tratamiento de la enfermedad de parkinson. |
| US9145402B2 (en) | 2011-11-29 | 2015-09-29 | Genentech, Inc. | Aminopyrimidine derivatives as LRRK2 modulators |
| KR102012057B1 (ko) | 2011-11-29 | 2019-08-19 | 제넨테크, 인크. | Lrrk2 조절제로서 아미노피리미딘 유도체 |
| EP2785381B1 (fr) | 2011-11-30 | 2016-05-18 | F.Hoffmann-La Roche Ag | Radioligands marqués par le fluor 18 et le carbone 11 pour une imagerie par tomographie par émission de positons (pet) pour lrrk2 |
| KR102091895B1 (ko) | 2012-05-03 | 2020-04-14 | 제넨테크, 인크. | 파킨슨병의 치료에 사용하기 위한 lrrk2 조절제로서의 피라졸 아미노피리미딘 유도체 |
| EP2844652B1 (fr) * | 2012-05-03 | 2019-03-13 | Genentech, Inc. | Dérivés de pyrazole aminopyrimidine en tant que modulateurs de lrrk2 |
| CN104736533B (zh) * | 2012-08-17 | 2016-12-07 | 癌症治疗合作研究中心有限公司 | Vegfr3抑制剂 |
| US10829484B2 (en) * | 2015-07-28 | 2020-11-10 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
| US11214565B2 (en) | 2015-11-20 | 2022-01-04 | Denali Therapeutics Inc. | Compound, compositions, and methods |
| US11028080B2 (en) | 2016-03-11 | 2021-06-08 | Denali Therapeutics Inc. | Substituted pyrimidines as LRKK2 inhibitors |
| SMT202100699T1 (it) | 2016-06-16 | 2022-01-10 | Denali Therapeutics Inc | Pirimidin-2-ilammino-1h-pirazoli come inibitori di lrrk2 per l'uso nel trattamento di disturbi neurodegenerativi |
| WO2018217946A1 (fr) | 2017-05-24 | 2018-11-29 | Denali Therapeutics Inc. | Composés, compositions et procédés |
| EP3717473B1 (fr) | 2017-11-21 | 2024-01-10 | Denali Therapeutics Inc. | Polymorphes et formes solides d'un composé de pyrimidinylamino-pyrazole, et procédés de production |
| CN112088003B (zh) | 2017-12-20 | 2023-10-13 | 戴纳立制药公司 | 制备嘧啶基-4-氨基吡唑化合物的工艺 |
| AR118641A1 (es) | 2019-04-11 | 2021-10-20 | Denali Therapeutics Inc | Compuestos, composiciones y métodos |
-
2018
- 2018-12-19 CN CN201880089536.1A patent/CN112088003B/zh active Active
- 2018-12-19 CA CA3086182A patent/CA3086182A1/fr active Pending
- 2018-12-19 KR KR1020207020841A patent/KR20200100757A/ko not_active Abandoned
- 2018-12-19 MX MX2020006641A patent/MX2020006641A/es unknown
- 2018-12-19 AU AU2018392599A patent/AU2018392599A1/en not_active Abandoned
- 2018-12-19 IL IL275480A patent/IL275480B2/en unknown
- 2018-12-19 SG SG11202005752PA patent/SG11202005752PA/en unknown
- 2018-12-19 US US16/955,717 patent/US11834438B2/en active Active
- 2018-12-19 EP EP18892459.1A patent/EP3727377B1/fr active Active
- 2018-12-19 MA MA051339A patent/MA51339A/fr unknown
- 2018-12-19 WO PCT/US2018/066595 patent/WO2019126383A1/fr not_active Ceased
- 2018-12-19 ES ES18892459T patent/ES2975958T3/es active Active
- 2018-12-19 JP JP2020534236A patent/JP7284172B2/ja active Active
- 2018-12-19 BR BR112020012611-0A patent/BR112020012611A2/pt not_active IP Right Cessation
-
2023
- 2023-10-26 US US18/384,080 patent/US12497387B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2975958T3 (es) | 2024-07-18 |
| US12497387B2 (en) | 2025-12-16 |
| JP2021506892A (ja) | 2021-02-22 |
| SG11202005752PA (en) | 2020-07-29 |
| EP3727377A1 (fr) | 2020-10-28 |
| KR20200100757A (ko) | 2020-08-26 |
| IL275480A (en) | 2020-08-31 |
| EP3727377A4 (fr) | 2021-08-18 |
| CN112088003B (zh) | 2023-10-13 |
| US11834438B2 (en) | 2023-12-05 |
| MX2020006641A (es) | 2021-01-08 |
| BR112020012611A2 (pt) | 2020-12-08 |
| IL275480B2 (en) | 2023-10-01 |
| CN112088003A (zh) | 2020-12-15 |
| JP7284172B2 (ja) | 2023-05-30 |
| WO2019126383A1 (fr) | 2019-06-27 |
| EP3727377B1 (fr) | 2024-01-31 |
| IL275480B1 (en) | 2023-06-01 |
| US20210009566A1 (en) | 2021-01-14 |
| US20240158371A1 (en) | 2024-05-16 |
| CA3086182A1 (fr) | 2019-06-27 |
| AU2018392599A1 (en) | 2020-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA49752A (fr) | Procédés de préparation de composés de pyrrolidine | |
| EP3398960A4 (fr) | Procédé de préparation du sermaglutide | |
| MA54253A (fr) | Procédé de préparation de dérivés de 2-chloro-4-hétéroaryl-pyridimidines | |
| EP3349586A4 (fr) | Procédé de préparation d'un composé antifongique | |
| EP3500551A4 (fr) | Procédé de préparation de biphényles substitués | |
| MA42423A (fr) | Procédé de préparation d'un revêtement | |
| EP3766869A4 (fr) | Procédé simple de préparation d'avibactam | |
| EP3400197A4 (fr) | Procédé améliore de préparation de bleu isosulfane | |
| EP3436425A4 (fr) | Procédé de préparation amélioré de tartrate de butorphanol | |
| EP3696168A4 (fr) | Procédé de préparation de 2-chloro-5-trifluorométhylpyridine | |
| EP3539941A4 (fr) | Procédé de préparation triméthylolpropane | |
| EP3511313A4 (fr) | Procédé de préparation de 1,3-cyclohexanediméthanol | |
| EP3717016A4 (fr) | Procédé pour la préparation de composés coupleurs de médicaments | |
| EP3350154A4 (fr) | Procédé amélioré de préparation de dichlorhydrate de trientine | |
| EP3505525A4 (fr) | Procédé de préparation de rubusoside | |
| MA51339A (fr) | Procédé de préparation de composés pyrimidinyl-4-aminopyrazole | |
| EP3770239A4 (fr) | Procédé de préparation de microcapsules | |
| EP3981753A4 (fr) | Procédé de préparation de triphénylchlorométhane | |
| EP3444253A4 (fr) | Procédé de préparation de ad-35 | |
| EP3666756A4 (fr) | Procédé de préparation de lévétiracétam | |
| EP3455210A4 (fr) | Procédé de préparation de boscalide | |
| EP3733651A4 (fr) | Procédé de préparation de calcobutrol | |
| EP3359512A4 (fr) | Procédé de préparation de bromures organiques | |
| EP3786152A4 (fr) | Procédé de préparation de composé nitrile aromatique | |
| EP3395786A4 (fr) | Procédé de préparation de butadiène |